These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23745120)

  • 1. Fluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutations.
    Sato T; Yokota S; Uchida I; Okubo T; Usui M; Kusumoto M; Akiba M; Fujii N; Tamura Y
    Front Microbiol; 2013; 4():125. PubMed ID: 23745120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates.
    Morgan-Linnell SK; Becnel Boyd L; Steffen D; Zechiedrich L
    Antimicrob Agents Chemother; 2009 Jan; 53(1):235-41. PubMed ID: 18838592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone and multidrug resistance phenotypes associated with the overexpression of AcrAB and an orthologue of MarA in Yersinia enterocolitica.
    Fàbrega A; Roca I; Vila J
    Int J Med Microbiol; 2010 Nov; 300(7):457-63. PubMed ID: 20510648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced resistance to fluoroquinolones in laboratory-grown mutants & clinical isolates of Shigella due to synergism between efflux pump expression & mutations in quinolone resistance determining region.
    Taneja N; Mishra A; Kumar A; Verma G; Sharma M
    Indian J Med Res; 2015 Jan; 141(1):81-9. PubMed ID: 25857499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the AcrAB-TolC efflux pump to high-level fluoroquinolone resistance in Escherichia coli isolated from dogs and humans.
    Sato T; Yokota S; Okubo T; Ishihara K; Ueno H; Muramatsu Y; Fujii N; Tamura Y
    J Vet Med Sci; 2013 May; 75(4):407-14. PubMed ID: 23149545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
    Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs.
    Gibson JS; Cobbold RN; Kyaw-Tanner MT; Heisig P; Trott DJ
    Vet Microbiol; 2010 Nov; 146(1-2):161-6. PubMed ID: 20471187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates.
    Liu X; Lazzaroni C; Aly SA; Thungrat K; Boothe DM
    Vet Microbiol; 2014 Dec; 174(3-4):514-522. PubMed ID: 25465666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.
    Wang H; Dzink-Fox JL; Chen M; Levy SB
    Antimicrob Agents Chemother; 2001 May; 45(5):1515-21. PubMed ID: 11302820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
    Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
    Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Supermutators' found amongst highly levofloxacin-resistant E. coli isolates: a rapid protocol for the detection of mutation sites.
    Zayed AA; Essam TM; Hashem AG; El-Tayeb OM
    Emerg Microbes Infect; 2015 Jan; 4(1):e4. PubMed ID: 26038761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of fluoroquinolone resistance: an update 1994-1998.
    Piddock LJ
    Drugs; 1999; 58 Suppl 2():11-8. PubMed ID: 10553699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
    Chen S; Cui S; McDermott PF; Zhao S; White DG; Paulsen I; Meng J
    Antimicrob Agents Chemother; 2007 Feb; 51(2):535-42. PubMed ID: 17043131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of acrA and acrB Genes in Esherichia coli Mutants with or without marR or acrR Mutations.
    Pourahmad Jaktaji R; Jazayeri N
    Iran J Basic Med Sci; 2013 Dec; 16(12):1254-8. PubMed ID: 24570831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Different Mechanisms to Ciprofloxacin Resistance in
    Chang MX; Zhang JF; Sun YH; Li RS; Lin XL; Yang L; Webber MA; Jiang HX
    Front Microbiol; 2021; 12():663731. PubMed ID: 34025618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli.
    Yang S; Clayton SR; Zechiedrich EL
    J Antimicrob Chemother; 2003 Mar; 51(3):545-56. PubMed ID: 12615854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Fluoroquinolone Antibiotic Resistance Mechanism of Salmonella enterica Isolates.
    Kim SY; Lee SK; Park MS; Na HT
    J Microbiol Biotechnol; 2016 Sep; 26(9):1605-12. PubMed ID: 27116992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants Selected with a fluoroquinolone.
    Jellen-Ritter AS; Kern WV
    Antimicrob Agents Chemother; 2001 May; 45(5):1467-72. PubMed ID: 11302812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of plasmid-borne oqxAB on the development of fluoroquinolone resistance and bacterial fitness in Escherichia coli.
    Wang J; Guo ZW; Zhi CP; Yang T; Zhao JJ; Chen XJ; Zeng L; Lv LC; Zeng ZL; Liu JH
    J Antimicrob Chemother; 2017 May; 72(5):1293-1302. PubMed ID: 28160469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.